Pulmonx Historical Cash Flow

LUNG Stock  USD 8.68  0.24  2.69%   
Analysis of Pulmonx Corp cash flow over time is an excellent tool to project Pulmonx Corp future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Capital Expenditures of 802.6 K or Total Cash From Financing Activities of 33.3 M as it is a great indicator of Pulmonx Corp ability to facilitate future growth, repay debt on time or pay out dividends.
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Pulmonx Corp latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Pulmonx Corp is a good buy for the upcoming year.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Pulmonx Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For more detail on how to invest in Pulmonx Stock please use our How to Invest in Pulmonx Corp guide.

About Pulmonx Cash Flow Analysis

The Cash Flow Statement is a financial statement that shows how changes in Pulmonx balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Pulmonx's non-liquid assets can be easily converted into cash.

Pulmonx Corp Cash Flow Chart

At this time, Pulmonx Corp's Total Cash From Financing Activities is most likely to increase significantly in the upcoming years. The Pulmonx Corp's current Change To Netincome is estimated to increase to about 20.6 M, while Change In Cash is forecasted to increase to (15.5 M).

Capital Expenditures

Capital Expenditures are funds used by Pulmonx Corp to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Pulmonx Corp operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.

Stock Based Compensation

Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.
Most accounts from Pulmonx Corp's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Pulmonx Corp current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Pulmonx Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For more detail on how to invest in Pulmonx Stock please use our How to Invest in Pulmonx Corp guide.At this time, Pulmonx Corp's Total Cash From Financing Activities is most likely to increase significantly in the upcoming years. The Pulmonx Corp's current Change To Netincome is estimated to increase to about 20.6 M, while Change In Cash is forecasted to increase to (15.5 M).
 2022 2023 2024 2025 (projected)
Capital Expenditures1.3M807K928.1K802.6K
Depreciation1.5M1.5M1.8M1.9M

Pulmonx Corp cash flow statement Correlations

0.42-0.07-0.29-0.19-0.340.14-0.070.27-0.15-0.22-0.310.2-0.110.30.37-0.24-0.330.180.18-0.13
0.42-0.2-0.5-0.05-0.75-0.02-0.140.3-0.02-0.67-0.640.540.090.480.85-0.45-0.560.190.190.02
-0.07-0.20.89-0.22-0.270.62-0.290.15-0.34-0.290.430.59-0.270.20.08-0.480.460.450.45-0.37
-0.29-0.50.89-0.10.050.49-0.17-0.05-0.23-0.070.570.33-0.2-0.01-0.19-0.240.580.280.28-0.27
-0.19-0.05-0.22-0.10.5-0.79-0.59-0.950.990.260.57-0.120.98-0.85-0.460.740.65-0.92-0.920.98
-0.34-0.75-0.270.050.5-0.51-0.01-0.670.530.920.67-0.80.43-0.8-0.880.890.57-0.71-0.720.49
0.14-0.020.620.49-0.79-0.510.070.75-0.82-0.39-0.160.49-0.780.660.33-0.7-0.220.830.82-0.82
-0.07-0.14-0.29-0.17-0.59-0.010.070.52-0.570.15-0.57-0.51-0.630.510.2-0.28-0.620.470.46-0.6
0.270.30.15-0.05-0.95-0.670.750.52-0.93-0.41-0.70.26-0.90.940.65-0.81-0.760.920.92-0.92
-0.15-0.02-0.34-0.230.990.53-0.82-0.57-0.930.320.52-0.20.99-0.86-0.470.790.58-0.96-0.960.99
-0.22-0.67-0.29-0.070.260.92-0.390.15-0.410.320.52-0.870.24-0.6-0.740.760.38-0.53-0.540.27
-0.31-0.640.430.570.570.67-0.16-0.57-0.70.520.52-0.120.5-0.77-0.750.580.97-0.55-0.550.48
0.20.540.590.33-0.12-0.80.49-0.510.26-0.2-0.87-0.12-0.090.40.57-0.66-0.010.410.43-0.16
-0.110.09-0.27-0.20.980.43-0.78-0.63-0.90.990.240.5-0.09-0.8-0.350.710.57-0.91-0.910.98
0.30.480.2-0.01-0.85-0.80.660.510.94-0.86-0.6-0.770.4-0.80.84-0.92-0.770.930.93-0.85
0.370.850.08-0.19-0.46-0.880.330.20.65-0.47-0.74-0.750.57-0.350.84-0.81-0.690.630.63-0.45
-0.24-0.45-0.48-0.240.740.89-0.7-0.28-0.810.790.760.58-0.660.71-0.92-0.810.53-0.93-0.930.78
-0.33-0.560.460.580.650.57-0.22-0.62-0.760.580.380.97-0.010.57-0.77-0.690.53-0.56-0.560.54
0.180.190.450.28-0.92-0.710.830.470.92-0.96-0.53-0.550.41-0.910.930.63-0.93-0.561.0-0.95
0.180.190.450.28-0.92-0.720.820.460.92-0.96-0.54-0.550.43-0.910.930.63-0.93-0.561.0-0.95
-0.130.02-0.37-0.270.980.49-0.82-0.6-0.920.990.270.48-0.160.98-0.85-0.450.780.54-0.95-0.95
Click cells to compare fundamentals

Pulmonx Corp Account Relationship Matchups

Pulmonx Corp cash flow statement Accounts

202020212022202320242025 (projected)
Sale Purchase Of Stock(21K)(26K)(27K)1.2M1.1M885.7K
Change To Inventory(5.0M)(6.5M)(3.6M)918K826.2K867.5K
Change In Cash217.0M(83.1M)(46.7M)(18.2M)(16.4M)(15.5M)
Net Borrowings6M33.0M(41K)(140K)(161K)(153.0K)
Total Cashflows From Investing Activities(14.2M)12.7M(46.3M)(4.2M)(3.8M)(4.0M)
Depreciation483K867K1.5M1.5M1.8M1.9M
Capital Expenditures911K3.7M1.3M807K928.1K802.6K
Total Cash From Operating Activities(30.6M)(41.4M)(45.1M)(37.6M)(33.8M)(32.2M)
Change To Account Receivables1.5M(2.4M)(2.2M)(3.1M)(2.8M)(2.7M)
Change To Operating Activities2.0M(1.5M)848K(1.3M)(1.2M)(1.1M)
Net Income(32.2M)(48.7M)(58.9M)(60.8M)(54.8M)(52.0M)
Total Cash From Financing Activities234.8M4.5M2.5M21.4M24.6M33.3M
Change To Netincome1.9M1.9M11.7M17.0M19.6M20.6M
Change To Liabilities552K506K4.9M272K312.8K582.2K
End Period Cash Flow231.8M148.7M102.0M83.8M96.4M93.5M
Investments12.7M(42.6M)(2.9M)21K18.9K19.8K
Stock Based Compensation3.2M10.5M16.4M22.1M25.4M26.7M
Free Cash Flow(31.5M)(45.1M)(46.4M)(38.4M)(34.6M)(36.3M)
Change In Working Capital(4.8M)(7.8M)(7.0M)(2.6M)(2.3M)(2.4M)
Begin Period Cash Flow14.8M231.8M148.7M102.0M117.3M93.8M
Other Cashflows From Financing Activities446K4.5M2.5M1.5M1.3M1.3M
Other Non Cash Items5.5M2.5M2.8M2.1M2.5M2.5M

Currently Active Assets on Macroaxis

When determining whether Pulmonx Corp is a strong investment it is important to analyze Pulmonx Corp's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Pulmonx Corp's future performance. For an informed investment choice regarding Pulmonx Stock, refer to the following important reports:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Pulmonx Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For more detail on how to invest in Pulmonx Stock please use our How to Invest in Pulmonx Corp guide.
You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pulmonx Corp. If investors know Pulmonx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pulmonx Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.44)
Revenue Per Share
2.142
Quarterly Revenue Growth
0.233
Return On Assets
(0.21)
Return On Equity
(0.55)
The market value of Pulmonx Corp is measured differently than its book value, which is the value of Pulmonx that is recorded on the company's balance sheet. Investors also form their own opinion of Pulmonx Corp's value that differs from its market value or its book value, called intrinsic value, which is Pulmonx Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pulmonx Corp's market value can be influenced by many factors that don't directly affect Pulmonx Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pulmonx Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pulmonx Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pulmonx Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.